These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7697635)

  • 41. Genetic imbalance on chromosome 17 in papillary serous carcinoma of the peritoneum.
    Bandera CA; Muto MG; Welch WR; Berkowitz RS; Mok SC
    Oncogene; 1998 Jul; 16(26):3455-9. PubMed ID: 9692553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Establishment and characterization of a serous papillary adenocarcinoma cell line of the human ovary in a serum-free culture.
    Emoto M; Oshima K; Ishiguro M; Iwasaki H; Kawarabayashi T; Kikuchi M
    Pathol Res Pract; 1999; 195(4):237-42. PubMed ID: 10337661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
    Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK
    Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer.
    Tangir J; Muto MG; Berkowitz RS; Welch WR; Bell DA; Mok SC
    Oncogene; 1996 Feb; 12(4):735-40. PubMed ID: 8632895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Consistent occurrence of a 19p+ marker chromosome and loss of 11p material in ovarian seropapillary cystadenocarcinomas.
    Pejovic T; Heim S; Mandahl N; Elmfors B; Flodérus UM; Furgyik S; Helm G; Willén H; Mitelman F
    Genes Chromosomes Cancer; 1989 Nov; 1(2):167-71. PubMed ID: 2487157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sequence of centromere separation: occurrence, possible significance, and control.
    Vig BK
    Cancer Genet Cytogenet; 1983 Mar; 8(3):249-74. PubMed ID: 6337704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chromosome aberrations in metastatic ovarian cancer: relationship with abnormalities in primary tumors.
    Bello MJ; Rey JA
    Int J Cancer; 1990 Jan; 45(1):50-4. PubMed ID: 2298505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Phenotype--genotype--correlation in ovarian neoplasia].
    Diebold J
    Verh Dtsch Ges Pathol; 2001; 85():153-60. PubMed ID: 11894392
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chromosomal analysis in malignant ovarian tumors.
    Sonwalker AA; Grover S
    Am J Obstet Gynecol; 1974 Apr; 118(7):961-5. PubMed ID: 4361960
    [No Abstract]   [Full Text] [Related]  

  • 50. Premature separation of centromeres in marrow chromosomes from an untreated patient with acute myelogenous leukemia.
    Littlefield LG; Joiner EE; Sayer AM
    Cancer Genet Cytogenet; 1985 Mar; 16(2):109-16. PubMed ID: 3855690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma.
    Hermsen MA; Joenje H; Arwert F; Welters MJ; Braakhuis BJ; Bagnay M; Westerveld A; Slater R
    Genes Chromosomes Cancer; 1996 Jan; 15(1):1-9. PubMed ID: 8824719
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrent cytogenetic aberrations in human ovarian carcinomas.
    Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
    Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential expression of the ICF (immunodeficiency, centromeric heterochromatin, facial anomalies) mutation in lymphocytes and fibroblasts.
    Maraschio P; Tupler R; Dainotti E; Piantanida M; Cazzola G; Tiepolo L
    J Med Genet; 1989 Jul; 26(7):452-6. PubMed ID: 2746618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum.
    Huang LW; Garrett AP; Muto MG; Colitti CV; Bell DA; Welch WR; Berkowitz RS; Mok SC
    Hum Pathol; 2000 Mar; 31(3):367-73. PubMed ID: 10746681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas.
    Zheng J; Benedict WF; Xu HJ; Hu SX; Kim TM; Velicescu M; Wan M; Cofer KF; Dubeau L
    J Natl Cancer Inst; 1995 Aug; 87(15):1146-53. PubMed ID: 7674319
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytogenetic and FISH analysis of endometrial carcinoma.
    Shah NK; Currie JL; Rosenshein N; Campbell J; Long P; Abbas F; Griffin CA
    Cancer Genet Cytogenet; 1994 Apr; 73(2):142-6. PubMed ID: 8174089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytogenetic observations on two ovarian carcinomas with double minutes, one with a 6q- marker chromosome.
    Bullerdiek J; Bartnitzke S; Kahrs E; Schloot W
    Cytobios; 1985; 42(165):15-24. PubMed ID: 3858061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chromosomal losses of regions on 5q and lack of high-level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma.
    Staebler A; Karberg B; Behm J; Kuhlmann P; Neubert U; Schmidt H; Korsching E; Bürger H; Lelle R; Kiesel L; Böcker W; Shih IeM; Buchweitz O
    Genes Chromosomes Cancer; 2006 Oct; 45(10):905-17. PubMed ID: 16845658
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Band 1p36 abnormalities and t(1;17) in ovarian carcinoma.
    Thompson FH; Taetle R; Trent JM; Liu Y; Massey-Brown K; Scott KM; Weinstein RS; Emerson JC; Alberts DS; Nelson MA
    Cancer Genet Cytogenet; 1997 Jul; 96(2):106-10. PubMed ID: 9216715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative cytogenetic studies of benign, borderline, and malignant epithelial ovarian tumors.
    Izutsu T; Kudo T; Shoji T; Nishiya I
    J Obstet Gynaecol Res; 1996 Dec; 22(6):541-9. PubMed ID: 9037943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.